Elanco Animal Health Inc (ELAN): Free Cash Flow
$284.00M
Year ended 2025-12-31
$379.00M
Trailing 12 months to 2026-06-30
+0.4%
3-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $284.00M | -27.9% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $394.00M | +200.8% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $131.00M | -53.4% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $281.00M | -13.3% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $324.00M | n/c | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$176.00M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $84.00M | -76.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $352.80M | +369.1% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $75.20M | +64.9% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $45.60M | n/a | 2019-02-20, From 2016-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $284.00M | -27.9% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.30B | -4.5% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $145.10M | -40.7% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $941.74M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $465.38M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $538.00M | -29.6% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $724.96M | +48.7% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.04B | -3.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $269.93M | +11.0% |
Compare ELAN, JAZZ, PRGO, ONC side by side · Screen every company in Pharmaceutical Preparations ↗